The Centre for Medicines Discovery aims to catalyse the discovery
and development of new medicines for patients.
News
ASAP Discovery Consortium wins 2023 FASEB Dataworks prize
9 February 2024
Publications
-
Discovery of Conformationally Constrained ALK2 Inhibitors.
Journal article
González-Álvarez H. et al, (2024), J Med Chem
-
Covalent Fragment Screening and Optimization Identifies the Chloroacetohydrazide Scaffold as Inhibitors for Ubiquitin C-terminal Hydrolase L1.
Journal article
Imhoff RD. et al, (2024), J Med Chem
-
Still in Search for an EAAT Activator: GT949 Does Not Activate EAAT2, nor EAAT3 in Impedance and Radioligand Uptake Assays.
Journal article
van Veggel L. et al, (2024), ACS Chem Neurosci